Comparison with differential expression analysis revealed that ATP6V1D, ATP6V1G2, CLTB, and NSF were all downregulated (log2FC < 0) in AD (Table S2) and identified as protective factors against AD in the MR analysis, thereby defining them as potential biomarkers relevant to AD in this study. This evidence concerns the gene ATP6V1D and Alzheimer disease.